HCW BIOLOGICS INC. - C
0.4200
07-October-24 14:59:31
15 minutes delayed
Stocks
-0.0305
-6.77%
Today's range
0.4200 - 0.5100
ISIN
N/A
Source
NASDAQ
-
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
03 Aug 2022 06:15:00 By Nasdaq GlobeNewswire
-
23 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
13 May 2022 06:15:00 By Nasdaq GlobeNewswire
-
19 Apr 2022 06:33:00 By Nasdaq GlobeNewswire
-
28 Mar 2022 06:00:00 By Nasdaq GlobeNewswire
-
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
24 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
20 Jan 2022 07:00:03 By Nasdaq GlobeNewswire
-
19 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 – 13, 2022
06 Jan 2022 06:33:00 By Nasdaq GlobeNewswire
-
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year
13 Dec 2021 06:31:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
12 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
28 Oct 2021 06:00:01 By Nasdaq GlobeNewswire
-
24 Aug 2021 06:32:00 By Nasdaq GlobeNewswire
-
17 Aug 2021 06:32:00 By Nasdaq GlobeNewswire
-
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
13 Aug 2021 06:10:00 By Nasdaq GlobeNewswire
-
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
22 Jul 2021 15:05:00 By Nasdaq GlobeNewswire
-
HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering
19 Jul 2021 17:39:57 By Nasdaq GlobeNewswire